Unknown

Dataset Information

Birinapant Reshapes the Tumor Immunopeptidome and Enhances Antigen Presentation.


ABSTRACT: Birinapant, an antagonist of the inhibitor of apoptosis proteins, upregulates MHCs in tumor cells and displays a better tumoricidal effect when used in combination with immune checkpoint inhibitors, indicating that Birinapant may affect the antigen presentation pathway; however, the mechanism remains elusive. Based on high-resolution mass spectrometry and in vitro and in vivo models, we adopted integrated genomics, proteomics, and immunopeptidomics strategies to study the mechanism underlying the regulation of tumor immunity by Birinapant from the perspective of antigen presentation. Firstly, in HT29 and MCF7 cells, Birinapant increased the number and abundance of immunopeptides and source proteins. Secondly, a greater number of cancer/testis antigen peptides with increased abundance and m

SUBMITTER: Zhang W 

PROVIDER: S-EPMC11011986 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature